BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Breast
,
Nosology
,
Rosiglitazone
,
rs2230926
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NPM1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Granulocyte-macrophage progenitor cell of bone marrow
Hematopoietic stem cell of bone marrow
T Lymphocyte (regulatory) of peripheral blood
Parotid gland
Peritoneum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hepatocellular dysplasia
Bacterial pneumonia
Injury of eye region
Human immunodeficiency virus infection
Disease due to Lentivirus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane
tetrabrominated diphenyl ether 47
Methiocarb
calycanthine
1-amino-2,4-dibromoanthraquinone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NPM1
H2-Eb2
Idd1
Idd5
SMIM26
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1.
Nucleophosmin 1 overexpression enhances neuroprotection by attenuating cellular stress in traumatic …
Recent advances in AML with mutated NPM1.
Functions of the native NPM1 protein and its leukemic mutant.
Generation of a Rat Monoclonal Antibody for Human Nucleophosmin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Oral Arsenic Trioxide for NPM1-mutated AML
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged …
Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.
Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1…
Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ